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Summary 
T  cells bearing the class lI-restricted, DO-T  cell receptor (TCR) are CD4 ÷ if their thymocyte 
precursors are positively selected on the class II protein, IA  d, but they are almost all CD4- after 
positive selection on a class II for which they have higher avidity, IA  b. DO-TCR + T  cells ma- 
ture in H-2  b mice lacking CD4.  CD4  DO-TCR + T  cells appear in H-2  b mice at the same 
rate as their CD4 + counterparts appear in H-2  d animals, suggesting that the CD4- cells are not 
the product of some minor pathway of thymocyte development and selection.  In H-2  b CD4 
knock out mice expressing human CD2 under the control of the mouse CD4 promoter, ma- 
ture DO-TCR + cells did not express human CD2. These results suggest that the CD4  CD8-, 
DO-TCR + mature T  cells have developed without  ever passing through the  equivalent  of a 
CD4 +,  CD8 ÷  stage.  The  early expression  of c~/[3 receptors  (TCRs)  on thymocytes in TCR 
transgenic  mice  may  allow  maturation  of this  type.  Passage  through  the  equivalent  of the 
CD4+CD8 +,  double-positive  stage is not essential  for differentiation  of thymocytes into ma- 
ture T  cells. 
I 
n  normal mice,  most mature T  cells bearing 0#[3 TCR.s 
.express on their surfaces either CD4 or CD8 (1).  Usually 
T  cells bearing TCR.s which are specific for antigenic pep- 
tides bound to class I MHC  proteins bear also CD8, a pro- 
tein  which  can  engage  a  conserved  site  on  class  I  MHC 
molecules (2, 3). Likewise, T  cells bearing TCRs which are 
specific for antigenic peptides bound to class II MHC  pro- 
teins bear also CD4, which can engage a conserved site on 
class II MHC  (4-7). CD4 and CD8 probably contribute to 
T  cell responses in several ways, among them the fact that 
their  affinity for class  I  and  class  II, respectively,  increases 
the overall avidity with which thymocytes and T  cells  can 
react with their targets (8-10). 
Early thymocytes bear neither  CD4  nor CD8  (11,  12). 
As the cells mature,  however, both CD4 and CD8 appear 
on their surfaces and it is thought that it is at this stage that 
future expression of these proteins is determined,  either by 
a  random  choice,  followed  by  positive  selection  of cells 
bearing  the  protein  appropriate  to  the  specificity  of their 
TCRs  (13-16)  or by instructed  choice of the  appropriate 
protein based on the specificity of their TCR  (17,  18). 
A few mature a/13 TCR + T  cells in normal animals bear 
neither  CD4  nor  CD8  (19,  20).  Cells  of this  phenotype 
are, however, more frequent in diseased animals or in cer- 
tain  TCR  transgenic  mice.  Many T  cells  in  the  autoim- 
mune lpr/lpr strains of mice, for example, are CD4-, CD8- 
double  negative  (DN 1,  21).  These  T  cells  have  additional 
abnormalities,  for example,  they bear relatively low levels 
of TCR  on their surfaces, they are B220 ÷, and they do not 
respond to normal T  cell stimuli.  Double-negative  T  cells 
have also been detected in mice expressing some transgenic 
TCRs. Cells of this phenotype are particularly likely to ap- 
pear if the transgenic TCR  reacts with some antigen in its 
host. For example, DN T  cells were detected in male mice 
expressing  a  male  antigen~specific  TCR  (22).  Apart from 
the  fact that  they express  neither  CD4  nor CD8  the  DN 
mature T  cells  in TCR  transgenic  mice are not like those 
in lpr/lpr animals. They do not bear B220 and in some cir- 
cumstances they can respond to TCR  engagement. 
A  number  of investigators  have  tried  to  find  out  how 
these abnormal cells develop. The DN cells in lpr/lpr mice 
are thought to mature via a CD4+CD8 + stage, to be posi- 
tively selected by reaction with class I MHC proteins,  and, 
for  some  reason,  then  lose  expression  of both  CD4  and 
CD8  (23,  24).  In  contrast,  the  maturational  route  of the 
DN cells in TCR  transgenic mice is not well understood. 
In this article we have examined the way in which cells 
of this phenotype appear in mice expressing a particular set 
1Abbreviations  used in this paper:  cOVA, chicken OVA; DN, double nega- 
tive; KO, knockout. 
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chicken ovalbumin peptide (cOVA 323-339) bound to IA  d 
or  IA  b which has  also  a  low but appreciable reactivity for 
IA  b bound  to  an unknown  mouse peptide.  Cells bearing 
this TC1L (DO-TC1L) mature into CD4 + ceils in mice ex- 
pressing IA  d, but into DN  cells in mice expressing IA  b. Ex- 
periments  show  that  the  production  of DN  DO-TC1L + 
ceils in IA  b mice is an efficient event.  Cells of this pheno- 
type appear at the same rate as their CD4 + counterparts do, 
in lAd-expressing animals. The DN  DO-TClL + T  cells ap- 
pear in IA  b expressing mice even if CD4  is not expressed. 
We used a surrogate marker for CD4,  human CD2 driven 
by a CD4 promoter, to show that these DN  DO-TCR  + T 
cells are  not in the  CD4-expressing lineage,  and that  it is 
likely that  these  ceils mature  without passing through  the 
CD4+CD8 +  stage  of thymocyte  development.  Therefore 
this maturational stage must not be essential. 
Materials  and Methods 
Mice.  H_2  b, d, ork mice expressing the DO-11.10 TCIL trans- 
gene  were  obtained by  breeding DO-TC1L  transgenic BALB/c 
mice  (25)  with  C57BL/10,  B10.D2nSn,  or B10.BR  mice  ob- 
tained from The Jackson Laboratory, Bar Harbor, ME.  H-2  b or 
H-2  a, CD4-deficient (CD4 knockout [KO]) mice and CD4 KO 
mice  expressing human CD2  driven by  the  mouse  CD4  pro- 
moter were the kind gifts of Drs. Killeen (University of Califor- 
nia,  San  Francisco)  and  Littman  (New  York  University, New 
York)  (10,  26-29).  The  DO-TCR  transgenes were  introduced 
into these animals by two generation crosses with DO-TCR trans- 
genic BALB/c mice. DO-TCIL  + H-2  b or H-2  d, RAG-2 deficient 
mice  (RAG KO)  were  obtained in similar fashion using RAG 
KO animals kindly provided by Dr.  Fred Alt (Children's Hospi- 
tal,  Harvard Medical School,  Boston,  MA)  (30).  Mice  used in 
analysis were  4-12 wk old unless otherwise mentioned. All the 
mice were maintained in the specific pathogen-free Animal Care 
Facility at the National  Jewish Center. 
Production of Bone Marrow Chimeric Mice.  C57BL/10  H-2  b  mice 
were obtained from The Jackson Laboratory. H-2  b animals which 
do not express class I MHC proteins due to inactivation of the [32 
microglobulin gene (class I KO) were the kind gifts ofDrs. Koller 
and Smithies (University of North  Carolina, Chapel Hill)  (31). 
H-2  b class II-deficient animals (Class II KO, 32) were purchased 
from GenPharm (Mountain View, CA). DO-TCR +, H-2  b, CD4 
KO donor and C57BL/10, class I KO, and class II KO recipient 
animals were  treated  with 0.4 ml rabbit anti-mouse thymocyte 
serum (Accurate Chemical and Scientific, Westbury, NY) to re- 
move  mature  circulating  T  cells.  2  d  later  recipients  were 
irradiated with 950 rads from a cesium source and given 5  ×  106 
bone marrow  cells from  donors  intravenously. The  mice were 
maintained on acidified chlorinated water. 
Antibodies and Flow Cytometry.  The following antibodies used 
for staining were purified and conjugated in our laboratory: biotin- 
ylated-KJ1  (anti-DO-TCR idiotype, 33),  biotinylated-H57-597 
(anti-TCR.  C[3),  biotinylated-F23.2  (anti-TCR  V8.2),  FITC- 
conjugated GK1.5  (anti-CD4) were  purified and conjugated in 
the  laboratory;  anti-CD4-PE,  anti-CDS-FITC,  anti-B220-PE, 
anti-H-2  Da-FITC,  anti-H-2  Kb-pE,  anti-human  CD2-FITC 
and  streptavidin-Cychrome were  purchased  from  PharMingen 
(San Diego, CA). 
Single cell suspensions obtained from thymus and LN (pooled 
from inguinal, brachial, and axillary nodes), were filtered through 
nylon mesh (Falcon Labware, Becton Dickinson and Co., Frank- 
lin Lakes,  NJ), washed in balanced salts solution (BSS) and stained 
with antibodies at 1-3 ×  107cells/ml in staining buffer (BSS, 0.1% 
sodium azide, 2% fetal bovine serum). Two- or three-color stain- 
ing was  performed  as  follows.  Cells were  incubated with  10% 
normal mouse serum and a 10% culture supernatant of the anti-Fc 
receptor antibody 24.G2 (34) to block nonspecific binding of the 
staining antibodies. Primary antibodies were added to the cells in 
the presence of blocking agents,  incubated for 30  min at room 
temperature, and the cells were washed three times before addi- 
tion of the second reagent, streptavidin-Cychrome or streptavi- 
din-PE. Cells were incubated with the second reagents at 4°C for 
30 min. At least 104 cells were assessed on a FACScan  ® (Becton 
Dickinson and Co.,  San Jose,  CA)  and analyzed using the PC- 
LYSIS program (Becton Dickinson and Co.). 
Proliferation Assays.  Spleens and peripheral lymph nodes were 
teased through nylon mesh, and spleen cells were then subjected 
to ammonium chloride solution to lyse red blood cells. After one 
wash  with  BSS,  the  cells  were  maintained in DMEM  supple- 
mented with  10%  FBS, sodium bicarbonate, antibiotics, 2-ME, 
sodium pyruvate,  and nonessential amino acids.  Cells were  ti- 
trated in triplicate into the wells of 96-well flat-bottomed plates 
(Falcon Labware, Becton Dickinson and Co.) containing 5 ×  10 s 
irradiated  (3,000  rad  with  a  Cs  source)  splenocytes/well.  The 
cOVA 323-339 was used as antigen at 5 txM. Antibodies used for 
stimulation  were  fixed  to  Immulon  4,  96-well  flat-bottomed 
plates (Dynatech Laboratories, Chantilly, VA) at a concentration 
of 5-25  Ixg/ml during an overnight incubation at 4°C.  Nonat- 
tached  antibodies were  removed by five vigorous washes  with 
BSS before cell addition. Cells were cultured in these wells for 72 h 
at 37°C and incubated with 1 IxCi of [3H]thymidine (Amersham 
Corp., Arlington Heights, IL) per well, during the last 12-16 h of 
incubation. At the end of the incubation, cells were harvested on 
a Harvester 96 Mach III M  (Tomtec, Orange, CT) and the incor- 
poration was  determined on a Microbeta PLUS liquid scintilla- 
tion counter (Wallac, Turku, Finland). 
Southern Blot Analysis.  The  methylation  status  of the  CD8 
genes in thymocytes, T  cells, and liver cells was examined as pre- 
viously described (35).  DNA was digested with the indicated re- 
striction enzymes, blotted onto nitrocellulose filters, and probed 
with a PCR-amplified PstI-EcoRI DNA fragment of the Lyt-2 
gene  (36).  CD4+CD8 -,  CD4  CD8 +,  and CD4-CD8-  T  cells 
were  isolated  using affinity columns  (Biotex  Laboratories  Inc., 
Edmonton, Canada). 
Results 
Cells Expressing the DO-TCR  Behave Differently in Mice of 
Different MHC  Types.  T  hybridoma cells bearing the DO- 
TC1L and CD4  react well with  cOVA 323-339  bound to 
IA  b or IA  d and have no detectable ability to react with ei- 
ther  IA  d  or  IA  b in  the  absence  of the  ovalbumin peptide 
(37). CD4 + T  cells bearing the DO-TCR  which have ma- 
tured in H-2  d animals do, however, proliferate after transfer 
into  H-2  b  animals  (data  not  shown),  suggesting  that  the 
DO-TCR  may have a detectable affinity for IA  b bound to 
one  or  more  endogenous  mouse  peptides.  DO-TCR.- 
bearing  cells  react  with  the  antiidiotypic  antibody,  KJ-1 
(33).  This antibody was used to demonstrate that the DO- 
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Figure  1.  Phenotype  of ma- 
ture  thymocytes  and  T  cells in 
DO-TCR-transgenic  mice with 
various H-2 haplotypes. Thymus 
and LN cells were isolated from 
animals of different MHC haplo- 
types and stained for surface ex- 
pression of CD4,  CD8,  and  the 
DO-TCR as described in Mate- 
rials  and  Methods.  Shown  are 
the means and standard errors of 
the numbers of cells bearing high 
levels  of the  DO-TCtL  which 
were CD4+CD8-; CD4-CD8+; 
or DN in: (A) the thymuses and 
(/3) the  LN  of H-2  d ([2]); H-2  k 
([]); and H-2  b (m) mice. 
TC1K is expressed predominantly  on CD4 + T  cells in DO- 
TCR  transgenic H-2 d mice (25). 
To study  the influence of various H-2  molecules on the 
development of thymocytes,  the DO-TC1K transgenes  were 
crossed into mice of different H-2 haplotypes on the C57BL/ 
10  background.  The  numbers  of CD4 +  DO-TCR  +  cells 
were compared between the different types of mice (Fig.  1, 
A  and  B).  We  focused  our  studies  on  the  cells  that  bore 
high  levels  of the  DO-TC1K,  indicated  by  good  staining 
with KJ1  (DO-TCR.hi),  because  these  cells bore  the  DO- 
TCR  and  did  not  bear  appreciable  levels  of  any  other 
TC1K, as indicated by the fact that they did not stain better 
with  the  biotinylated  anti-C]3  antibody,  Ham-597,  than 
they  stained  with  the  biotinylated  antiidiotype  antibody, 
KJ1,  two  antibodies  known  to  stain  T  cell  hybridomas 
beating only the DO-TCR  equally well (data  not shown). 
Positive  and  negative  selection  of these  DO-TCR. hi  cells 
must  therefore  be  governed  by  the  DO-TCR  itself,  and 
not some other TC1K of unknown  specificity. 
DO-TCR  transgenic  mice which were homozygous for 
H-2 k  or  H-2  b  had  many  fewer  CD4 +  DO-TCP,. hi  cells 
than  H-2 a  mice  had  (Fig.  1,  A  and  B).  This  suggests  that 
thymocytes beating DO  receptors  only are either not posi- 
tively selected or are deleted in animals homozygous for H-2 
k  or b.  It  has  previously been  shown  that  T  cells bearing 
the DO-TCR  and CD4  are deleted by H-2  b (Murphy,  K., 
personal  communication).  To  confirm  this,  and  find  out 
why DO-TCR  +  T  ceils failed to appear  in H-2 k mice, we 
examined  the  fate  of these  cells  in  F1,  H-2  kxd,  or  H-2  bxd 
animals.  The  numbers  of CD4 +  DO-TCR  hi  cells  in  the 
thymuses  and lymph nodes of F1  H-2  k~*a mice were similar 
to those in H-2 a mice, whereas F1  H-2  bxa animals had very 
few  CD4 +  DO-TCR  hi  cells  in  their  thymuses  or  lymph 
nodes by comparison  with H-2  a animals  (Fig. 2,  A  and  B). 
These results indicated that thymocytes bearing the DO  re- 
ceptor  are  not deleted  by  molecules  associated with  H-2  k, 
and therefore the lack ofCD4 + DO-TCP,. hi cells in animals 
expressing  H-2 k  is  due  to  lack  of positive  selection.  By 
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Figure 2.  H-2  b deletes and H-2  k does not pos- 
itively  select  CD4  + T  cells bearing  the  DO- 
TCR. Thymus and LN cells were isolated from 
animals  of  different  MHC  haplotypes  and 
stained  as  described  in  the  legend  to  Fig.  1. 
Shown are the means and standard errors of the 
numbers  of cells bearing high levels of the DO- 
TCP. and CD4 in (A) the thymuses and (/3) the 
LN  of  H-2  d  (IS]); (kxd)F1  ([~); H-2  k  ([]); 
(bxd)F1 (l); and H-2  b (i) mice. 
1621  Liu et al. Table  1.  Cellularity of DO-TCR Transgenic Thymuses of 
Different MHC Types 
MHC Type 
H_2 a  H_2  b  H_2 k 
Cells/Thymus 
(x 10  8)  1.6  ----- 0.35  1.3  +  0.3  3.5  --+ 0.45 
Thymuses were removed from 4- to 8-wk-old mice. 
Results shown are mean +  SE. 
contrast,  expression of H-2  b,  even in heterozygotes,  caused 
the disappearance  of CD4 + DO-TCR  hi cells and therefore 
the  absence  of such  cells  in  H-2  b  homozygotes  is  due  to 
negative selection. 
In spite  of the  fact  that  H-2 b expression  is  tolerogenic 
for T  cells bearing  the  DO-TCR,  it is.interesting  to  note 
that  the  thymus  cellularity of H-2 b adult  mice was  not re- 
duced by comparison with that  of H-2  d animals  (Table  1). 
Perhaps  this  is because  the  DO-TCR  does  not  react  very 
strongly  with  H-2  b,  as  witnessed  by  the  fact  that  mature 
DO-TCR-bearing  T  cell hybridomas  do  not secrete  IL-2 
in  response  to  H-2 b (37)  although,  as noted  above,  CD4 + 
DO-TCR  +  T  cells  can  respond  to  H-2  b in  vivo.  On  the 
other  hand,  the  thymuses  of H-2  k  DO-TCR  transgenic 
mice  contain  many  more  thymocytes  than  do  the  other 
thymuses.  This  result  suggests  that,  by  some  unknown 
mechanism,  positively selected mature  thymocytes  control 
and reduce the numbers  of precursor cells in the organ. 
In summary, mice homozygous for H-2 d, k, or b provide 
positively selecting, nonselecting,  and deleting backgrounds, 
respectively,  for  CD4+CD8 -  thymocytes  expressing  high 
levels of the DO-TCR.  These mice were used to examine 
these phenomena  in greater detail as described below. 
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Relatively strong  interactions  between  TCR  and  class II  Figure  3. 
MHC allow positive  selection  in the absence of CD4.  The DO-TCR 
transgene was bred into CD4 KO mice expressing H-2  b (I) or H-2  d (IN) 
as described in Materials and Methods.  Shown are the means and standard 
errors of the numbers of cells in the LN of each mouse beating high levels 
of the DO-TCR and CD8, not CD4, or neither CD4 nor CD8~ 
Expression  of H-2 ~ Causes  the  Appearance  of DO-TCR hi 
CD4- Mature T  Cells.  Many  of the  LN  T  cells  in  H-2  b 
mice  bore  high  levels  of the  DO-TCR  and  were  either 
DN  or CD4-CD8  +  (Fig.  1  B).  These cells stained  equiva- 
lently with the anti-DO  idiotypic antibody,  KJ1,  and anti- 
body  to  TCR  C~  (data  not  shown),  therefore the  cells 
probably  bore  a  single  TCR  that  encoded  by  the  DO- 
TCR  transgene.  The results  suggested  that  interaction  be- 
tween  this  TCR  and  1A  b  in  the  thymus  allowed  positive 
selection  of cells  expressing  neither  CD4  nor  CD8  or  of 
cells expressing only CD8. 
Several experiments were done to check that this was in- 
deed  the  case.  In  the  first,  the  DO-TCR  transgenes  were 
crossed  into  mice  that  could  not  express  CD4  (CD4  KO 
animals,  26,  27).  As shown in Fig. 3, very few DO-TCR  hi 
T  cells  of any  CD4/8  phenotype  appeared  in  the  LN  of 
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Figure  4.  Cells beating the DO- 
TCR are  selected  by reaction  with 
class II MHC regardless of their sub- 
sequent phenotype.  Normal C57BL/ 
10  or  62  microglobulin-deficient 
(class  I  KO)  or  class ll-deficient 
(class  II  KO)  mice were  irradiated 
and reconstituted  with bone marrow 
from DO-TCR  transgenic  mice as 
described in Materials and Methods. 
6 wk after irradiation and bone mar- 
row reconstitution,  LN T cells in the 
recipient mice were analyzed for ex- 
pression  of high levels of the DO- 
TCR  and  CD4  and  CD8.  Shown 
are the means and standard errors of 
the  numbers  of DO-TCR  hi  cells/ 
LN of three recipient animals which 
were: (A) CD4-CD8 + or (/3) DN. Thymus 
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Figure 5.  The phenotypes  ofthymocytes and T cells in mice that express only the DO-TCR. The DO-TCR transgene was bred into RAG KO mice 
expressing H-2  b or H-2  d and thymocytes and LN from these animals were analyzed for expression of CD4, CD8, and the DO-TCR as described in Ma- 
terials and Methods.  Shown are the dot plots of CD4 vs CD8 staining of thymus and LN cells from H-2  b or H-2  a RAG KO mice. The percentages of 
CD4+CD8  , CD4-CD8 ÷, or DN cells in each of these populations is indicated on the dot plot next to the appropriate gated region. The adjacent histo- 
grams illustrate the levels of DO-TCR stained on each of the gated populations.  The numbers on the histograms represent the percentage  of cells in the 
region bearing high levels of the DO-TCR. The average total number ofceUs are: 2-3 ×  10  7 in thymus and 1.5-3 X 10  6 in LN of both H-2  d and H-2  b 
animals. 
CD4  KO,  H-2 d mice. On  the other hand,  CD4  KO,  H-2 b 
animals contained many cells lacking CD4 but beating high 
levels  of the  DO-TCR  without  or  with  coexpression  of 
CD8.  These  results  show  that  CD4  expression  is  not  re- 
quired  at  all  for  positive  selection  of thymocytes  beating 
the DO-TCR  in H-2 b thymuses. 
It was possible that these cells were not selected by reac- 
tion  with  the  class  II  protein  expressed  in  H-2  b,  IA  b,  but 
rather  by  reaction  with  one  of the  classical or nonclassical 
class  I  proteins  coded  by  this  haplotype.  To  check  this, 
DO-TCP,_ transgenic thymocytes were tested for their abil- 
ity to mature  in thymuses  that  could not express either the 
class  I  or  the  class  II MHC  proteins  of H-2  b.  Thus,  bone 
marrow cells from CD4  KO, DO-TCR  +, H-2 b mice were 
used to reconstitute lethally irradiated H-2  b mice that could 
not express either [32-microglobulin  (class I KO, 31)  or the 
1623  Liu et al. 
[3 chain of I-A  b (class  II KO, 32). As shown in Fig. 4, T  cells 
bearing high levels of the DO-TCP,  with or without CD8 
appeared  in  good  numbers  in  wild-type  control  animals, 
and in class I KO  mice, but were few in number in class II 
KO  mice. Therefore,  in H-2  b animals,  thymocytes beating 
the DO-TCR  are positively selected by reaction with I-A  b 
but  not with  I-A  d and  this  event does  not require  expres- 
sion of CD4. 
Finally, in spite of the fact that  the cells assessed in these 
experiments bore high levels of the DO-TCR,  it remained 
possible  that  some  of these  cells  had  rearranged  genes  for 
other TCR. ot  and/or  [3  chains,  and  that  low level expres- 
sion of these other genes was affecting our results.  To con- 
trol for this, the DO-TCI:(  transgenes were bred into H-2 d 
or H-2  b mice lacking expression of RAG-2  gene (RAG KO, 
30).  These  mice cannot  rearrange  and  express  other TCR. 12.5 - 
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Figure 6.  DN T cells bearing the DO-TCP, accumulate at high rate in 
the lymph nodes of H-2  b mice. The numbers of cells bearing high levels 
of the DO-TCR and various combinations of CD4 and CD8 in the LN 
of DO-TCR transgenic mice of various ages were measured using flow 
cytometry. Shown are the means and standard errors of these numbers 
derived from at least three  mice of each age. CD4+CD8 -  H-2  b ('); 
CD4+CD8 -  H-2  d (R); CD4-CD8 + H_2  b (~); CD4-CD8 + H_2  d (A); 
DN H-2  b (0); DN H-2  d (O). 
genes. Thymocytes and LN cells from these mice were ex- 
amined for the phenotypes of the DO-TCR.-bearing cells. 
Since T  ceils bearing the DO-TCR.  and CD4  are posi- 
tively selected by reaction with I-A  d, we were not surprised 
to find that CD4 + DO-TCR  + cells were well represented 
in the thymuses and LN of H-2 d, RAG KO animals (Fig. 5). 
However, it is worth noting that even in these H-2  d mice a 
few thymocytes and LN cells bore high levels of the DO- 
TCR  and CD8, not CD4. 
As the results described above had led us to expect, not 
only the LN but also the thymuses of RAG KO H-2  b ani- 
mals contained many cells bearing high levels of the DO- 
TCI< and neither CD4 nor CD8.  To a lesser extent, these 
animals also contained DO-TCR  hi thymocytes and T  cells 
bearing CD8 and not CD4. Almost all of the CD4 + cells in 
these animals bore reduced levels of the DO-TCR. 
Collectively, these results show that thymocytes bearing 
the DO-TCR  are selected much more efficiently on IA  d if 
they  coexpress  CD4.  By  contrast,  selection  of these  thy- 
mocytes  on  I-A  b  does  not  require  coexpression  of CD4 
and, in fact, most of the cells selected by reaction between 
the DO-TCR  and IA  b but not IA  d do not express CD4 or, 
indeed, CD8.  Selection on IA  b and, to a lesser extent, IA  d, 
does create some mature  cells bearing the  "inappropriate" 
accessory  protein,  CD8.  Thus  the  MHC  protein  with 
which  the  TCR  reacts  during positive selection does not 
always determine the CD4 or CD8 phenotype of the T  cell 
which is produced. 
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DN  DO-TCR hi  Cells  Are  Produced  by  an  Active  Process. 
The  results  described above show  that  DN  DO-TCR  hi 
T  cells are the major T  cell population in DO-TCR  trans- 
genic H-2  b mice. However, the data do not indicate how 
these cells are generated. For example, the data do not in- 
dicate whether these cells accumulate slowly as a result of a 
minor thymus maturation pathway, or rapidly, driven by a 
dominant route.  Two sets of data bear on the matter. The 
first set derives from the data in Fig. 5 which indicate that 
not  only periphery tissues, but  also the  thymuses  of H-2  b 
mice  contain  increased numbers  of DN  DO-TCP,. hi  cells 
by comparison with lymph nodes and thymuses from H-2  d 
mice. Secondly, we compared the numbers  of cells of dif- 
ferent  subsets present in  the  LN  of mice  at  different ages 
(Fig. 6).  The results show that the DN DO-TCR  hi cells in 
the periphery of H-2  b mice accumulate at the same rate as 
their CD4 + counterparts in H-2  d animals. Perhaps appear- 
ance  of these  cells is  due  to  directed down-regulation of 
CD4  gene  expression caused by the strength  of the signal 
generated  by  reaction  of the  DO-TCP,.  with  IA  b in  the 
thymus. Alternatively, the DN mature T  cells might be se- 
lected randomly but expand rapidly to fill the void created 
by  the  absence  of other  T  cells.  Lastly, it is possible that 
these  cells may be selected at the DN  stage of thymocyte 
development without ever becoming CD4+CD8 + cells. 
DO-TCR + Mature T  Cells Develop without Passing through 
the Equivalent  of a CD4+ CD8  + Stage.  Three  different  pro- 
tocols were  used to  test the  idea that  DO-TCR. +  T  cells 
might  mature  without  passing through  a  CDS-expressing 
stage.  In  the  first,  we  injected  DO-TCR. +,  R.AG-2 -/- 
H-2  bd  newborn  mice  with  anti-CD8  antibodies  to  see 
whether  development  of these  cells was  blocked  as  pre- 
dicted by previous studies on chimeric mice  (38).  The re- 
sults showed that the anti-CD8  antibody did not interfere 
with  the  development  of  these  cells  (data  not  shown). 
However, it did not block the appearance of CD4 + T  cells 
in control animals, so this experiment was inconclusive. 
We have previously shown that the methylation status of 
the CD8  gene indicates whether or not T  cells have passed 
through a stage during which CD8  is expressed. In normal 
mice, restriction enzyme analysis reveals that the CD8 gene 
is undermethylated in CD4 + mature T  cells, indicating that 
these cells are derived from precursors that expressed CD8 
(35).  We  applied  this  technique  to  DNA  from  the  DN 
DO-TCR  +  T  cells  in  H-2  b  mice.  As  shown  in  Fig.  7, 
BamHI  digestion alone yields an  8-kb band  for the  CD8 
gene  in  DNA  from  all  tissues.  Double  digestion  with 
BamHI and MspI, a restriction enzyme that is not sensitive 
to  the  methylation  status  of  the  DNA  it  is  digesting, 
yielded,  from  all  tissues  tested,  a  dominant  2.8-kb  band 
which  hybridized  to  the  CD8  probe.  Double  digestion 
with  BamHI  and  HpalI,  a  methylation-sensitive isoschi- 
zomer  of MspI,  yielded different  results,  however.  Liver 
DNA gave a major 8-kb band after such digestion, indicat- 
ing that the HpalI sites in the CD8  gene in liver DNA are 
methylated. By contrast, DNA  from CD8 + mature T  cells 
i yielded a major band at 2.8 kb with a minor band at 4.3 kb 
and faint bands at 8 and 3.4 kb, indicating almost complete 
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Figure  7.  The  methylation 
pattern  of  the  CD8  gene  in 
CD8- transgenic  T cells is differ- 
ent from that of normal CD4  + T 
cells.  The  methylation  status  of 
the  CD8  genes  of various  cell 
populations  was  determined  by 
restriction enzyme digestion and 
Southern analysis as described  in 
Materials  and  Methods.  Thy- 
mocytes  from  C57B1/10  fetal 
mice  of embryonic ages  day  15 
and  19  were used as  sources of 
DN  and  CD4+CD8 +  cells, re- 
spectively. 
absence of methylation of the HpalI sites in the CD8  gene 
in these cells. The pattern of the  CD8  genes from CD4 + 
T  cells from  normal  mice  showed  that  these  genes  were 
somewhat  more  methylated than  those  of CD8 +  T  cells, 
since they yielded bands of equal intensity at 5.0,  4.3,  3.4, 
and 2.8 kb. The  digestion patterns of the CD8  genes from 
the DN  DO-TCR  ÷ T  cells from H-2  b mice, and from the 
CD4 + DO-TCR  + T  cells from H-2  d mice were similar to 
each  other with a  major band at  8  kb and minor bands at 
5.0,  4.3,  3.4,  and 2.8  kb.  This  pattern is intermediate be- 
tween  that  of DN  day  15  immature  thymocytes,  which 
have never expressed CD8, and that ofCD4+CD8 + imma- 
ture  thymocytes.  These  results  suggest  that  the  mature 
DO-TCR  + T  cells may have spent little or no time as im- 
mature  CD4+CD8 +  thymocytes,  whether  or  not  they 
eventually express CD4. 
Because neither of the experimental approaches described 
above was conclusive, we developed a third protocol to test 
the idea that in H-2  b animals DO-TCR  + T  cells might ap- 
pear without  passing through  the  double-positive stage of 
thymocyte existence. To  do this mice were created which 
expressed the DO-TCR  and human CD2 as a surrogate for 
mouse CD4, that is, the mice did not express CD4 and car- 
ried a transgene for human CD2 driven by the mouse CD4 
promoter  (CD4  KO,  huCD2 ÷, 26-29).  We  reasoned that 
expression of human  CD2  on T  cells in these mice should 
indicate whether  or not  these  cells had  differentiated into 
the CD4-expressing pathway without the disadvantage that 
mouse  CD4  engagement  might  deliver  an  inhibitory  or 
tolerizing signal to the  cells. It is unlikely that the huCD2 
itself would deliver such a signal since expression of human 
CD2  does not affect the overall developmental pathway of 
thymocytes  (39).  Moreover,  all  the  thymocytes  in  these 
studies  already expressed  high  levels  of mouse  CD2  (40) 
which  would presumably already be  delivering any  signal 
mediated by this molecule (41). 
As has  previously been  reported,  expression of huCD2 
driven by a CD4 promoter had no detectable effect on the 
development of thymocytes in CD4 KO animals (29).  Most 
of the mature T  cells which appear in such mice are CD8 + 
and very few of the peripheral T  cells are huCD2 ÷  (Fig. 8 
A). Likewise, the presence of the huCD2  transgene had no 
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effect  on  the  phenotype  of the  T  cells which  matured in 
DO-TCR  transgenic, H-2  b mice. The DO-TCR  + mature 
T  cells in H-2  b mice expressing huCD2  as a  surrogate for 
mouse  CD4  had the same phenotype as their counterparts 
in  mice lacking the  huCD2  transgene  (Fig.  8  B).  That  is, 
most  of the  DO-TCR  ÷  T  cells  were  huCD2-,  CD8-, 
and,  of course,  CD4-.  A  few  of the  DO-TCR  +  T  cells 
did express huCD2,  so expression of this gene was not le- 
thal to cells of this type, but the vast majority of the mature 
DO-TCR  + T  cells in these mice were huCD2-.  These re- 
sults  demonstrated  that  the  phenotype  of the  CD4-  DO- 
TCR ÷  T  cells in  IA  b mice was  not  due  to  some reaction 
driven  by  CD4  itself.  Rather,  it  seemed  that  these  cells 
could exist without induction of CD4 at all. 
The  DO-TCR +  Cells  Positively Selected  by  Reaction  with 
IA b Are Functional.  We  wished  to  find  out  whether  the 
unusual  CD4-  DO-TCR  +  T  cells  in  H-2  b  animals  cells 
could  respond  normally  to  stimulation  via  their  TCRs. 
Therefore  T  cells  from  DO-TCR  transgenic,  H-2  b,  and 
H-2 d mice were titrated for their ability to respond to syn- 
geneic  APC  and  cOVA  323-339  or to  plate-bound anti- 
TCR  antibodies. T  cells from H-2  b mice responded to the 
OVA peptide plus IA  b (Fig. 9).  Their response was not as 
good as that  of T  cells from H-2  d animals, however.  This 
was partly because IA  b does not present cOVA 323-339  to 
the  DO-TCR  as  well  as  IA  d does  (data not  shown),  and 
partly because  the  response  of DO-TCR  +  T  cells to  the 
peptide is augmented by coexpression of CD4  (8) and the 
DO-TCR  + T  cells from H-2  b mice lack CD4.  The T  cells 
responded equally well to anti-CD3 or anti-TCR CI3 anti- 
bodies, regardless of their strain of origin (Fig. 9), therefore 
there  is no  indication that  the  CD4-  DO-TCR  +  T  cells 
from H-2 b animals are not functional. 
Discussion 
Some  years  ago  it  was  suggested  that  the  fate  of thy- 
mocytes  is  determined  by  the  affinity  with  which  their 
TCRs  react  with  peptide/MHC  complexes  presented  in 
the thymus cortex. High affinity reactions would cause the 
thymocyte involved to  die,  intermediate affinity reactions 
would lead to positive selection, and very low or undetect- A  B 
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Figure  8.  The DN DO-TCR  + T cells that mature in IA  b mice probably  do not pass through a CD4+CD8  + stage in the thymus. The DO-TCR trans- 
gene was crossed into H-2  b mice which lacked expression of CD4 and contained a human CD2 transgene  driven by the mouse CD4 promoter and en- 
hancer. LN T cells from DO-TCR nontransgenic  (A) and transgenic (B) 6-8-wk-old mice were purified and stained for expression of human CD2, 
mouse CD8, and TCR C~ (left) or the DO-TCR (right). The upper dot plots show the profile of human CD2 vs CD8 expression. The lower histograms 
show the levels of expression of TCR C~ or the DO-TCR on LN cells that were, from left to right in each panel, human CD2  +, CD8-; human 
CD2-CD8+; human CD2-CD8-. Numbers on the dot plots show the percentage of total LN cells which fell into the indicated regions. Numbers on 
the histograms show the percentage of total LN cells which fall  into the indicated  C or DO-TCR staining  gates. 
able affinity would leave the  thymocyte to  die of neglect 
(42).  Recent experiments have  supported this hypothesis, 
with the  additional caveat that positive selection may de- 
pend on the avidity of the reaction between the thymocyte 
and selecting stromal cells,  rather than  the  affinity of the 
TCR for peptide/MHC (43-45). The avidity of the inter- 
action is crucial because it affects  the stability of TCR  en- 
gagement by ligand, and hence the strength of signal trans- 
duction  through  the  TCR.  It  may  also  be  important 
because thymocyte surface proteins such as CD4 and CD8 
which  increase  avidity by  binding to  ligands  on  stromal 
cells may transduce signals themselves which contribute to 
the selecting signal (46-48). However, "accessory protein" 
signals, such as those transduced through CD4, may not be 
essential for positive selection (9,  10, 49). 
The work described in this paper certainly supports these 
ideas.  IA  d  allowed  the  positive  selection  of thymocytes 
bearing the  DO-TCR  only if the  thymocytes bore  CD4 
since selection did not occur in CD4 KO, H-2  d mice. On 
the other hand, IA  b, which probably reacts with the DO- 
TCR with higher affinity than IA  d does, did drive positive 
selection of DO-TCR +  thymocytes whether or not CD4 
was  expressed.  Since signals transduced through  CD4  are 
therefore not essential for thymocyte-positive selection, one 
interpretation of this result is that the role of CD4 and/or 
CD8  in positive selection is  not  to  transduce signals but 
rather to increase the avidity with which thymocytes inter- 
act with stromal cells and therefore effectively increase the 
signal transduced through TCRs.  Alternatively, however, 
signals transduced through CD4 may contribute to the pos- 
itively selecting signal delivered to the DO-TCR-bearing 
thymocyte selected on the weaker ligand, IA  a. 
How  do  the  CD4  ,  class  II-restricted T  cells  arise,  in 
such large  numbers in  IA  b mice  and even,  admittedly in 
low numbers, in IA  d animals? In H-2  b animals most of the 
mature T  cells bearing the DO-TCR  express neither CD4 
nor CD8.  The phenotype of these cells is therefore some- 
what reminiscent of that of the DN  cells which appear in 
other,  special,  situations. However,  we  do  not think that 
these cells are analogous to most of these others. For exam- 
ple, DN T  cells appear in Fas- or Fas ligand-deficient ani- 
mals. However the  cells that appear in Fas-deficient mice 
1626  T Cell Development Directly from CD4  CD8- Thymocytes == 
¢, 
o~ 
0 
L, 
¢J 
~J 
.=. 
"0 
,.¢ 
o'3 
A 
1 0 7 
1 0 6 
1 0 5 
1 04~ 
1 08 
1 02 
1 0 2  1 0 3  1 0 4 
........  |  ........  I 
1 0 5  1 0 6 
........  |  "  '  ......  I  '  '  '''"'1 
1 0 3  1 0 4  1 0 5  1 0 6 
B 
1"  .......  I  ........  I  ........  I  ........  I 
02  1 03  1 04  1 05  1 06 
C 
1 0 6 
1 0 5 
1 0 4 
1 0 3 
1 0 2 
1 O  1 
1 O  2 
DO-TCR+ Ceils/Well 
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(O); H-2  b, RAG KO (A). 
are B220 + and most are selected on class I (50-52). Neither 
of these properties  characterizes  the  DN  DO-TCR +  ceils 
which arise in lAb-expressing mice.  Their requirement  for 
selection on class II also indicates that the DN DO-TCR + 
cells in H-2  b mice are not related to the recently described 
DN cells  specific for nonclassical class I-presented antigens 
(28,  53).  The DN  DO-TCR + T  cells  may have  matured 
by the pathway that governs ~//8 T  cell development. Un- 
like ~//8 cells,  however, these cells require a specific class II 
MHC for positive selection since they do not appear in H-2  k 
mice,  nor in animals  that lack class  II. Finally,  von Boeh- 
mer et  al.  have  reported  that DN  T  cells  mature  in mice 
transgenic for a TCR  specific for an HY peptide bound to 
D b (22).  These  T  cells  did  not,  however,  require  positive 
selection on their expected MHC  selecting protein,  D b, so 
these cells do not appear tO be related to the cells described 
in this paper, which do require positive selection on a spe- 
cific class II molecule, IA  b. 
Thus  the  DN  DO-TC1K  +  cells  produced  in  H-2  b ani- 
mals appear to be normal, class II-restricted T  cells in all re- 
spects  except  one:  their  lack  of CD4.  Their  appearance 
may be explained in one of three ways. First, the positively 
selecting signal that  causes thymocytes to stop synthesis  of 
either  CD4  or  CD8  may,  with  some  probability,  some- 
times cause thymocytes to stop synthesis of both CD4 and 
CD8.  Secondly,  inhibition  of synthesis  of both  CD4  and 
CD8 may actually be driven by the positively selecting sig- 
nal, if the signal is high, but not quite high enough to cause 
the  thymocyte to  die.  Thirdly,  in  TC1K  transgenic  mice, 
TCRs  are  expressed  on  the  surface  of thymocytes before 
they become CD4+CD8 + and selection in this case may al- 
low development of DN  T  cells  which have never passed 
through the double positive stage. All of these ideas require 
that  the  selecting  signals  delivered  to  thymocytes  by  en- 
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gagement of the DO-TCR  by IA  b is at just the right level, 
such that additional  signals from CD4 or CD8 are not re- 
quired,  and the signal is just large enough to allow positive 
selection but not clonal deletion of CD4  cells. 
Several results argue in favor of the last of these hypothe- 
ses.  First,  DN  DO-TCR +  T  cells  appear  at  considerable 
rate in H-2  b mice, suggesting that they are not the product 
of some  minor pathway  of T  cell  development.  Second, 
their  CD8  genes  are  not  as  undermethylated  as  those  of 
mature  normal  T  cells  which  have  developed  through  a 
CD8 +  stage.  Third,  these  cells  do  not  express  unrelated 
genes  under  the  control  of the  CD4  promoter,  even  if 
CD4 has never been expressed on the cells.  Hence the fact 
that they do not express these CD4 promoter driven genes 
cannot be due to some selective pressure caused by CD4 it- 
self.  Finally,  although DN  ot/[3 TCfk  +  T  cells are present 
in normal nontransgenic mice, they are a very minor popu- 
lation.  Were their appearance to be simply a matter of the 
appropriate affinity of TCtk for selecting ligand, one might 
have  predicted  that  a  number  of TCRs  might  satisfy this 
requirement,  and that such a population might therefore be 
more numerous  in normal animals than it is.  More likely, 
the  appearance  of oL/13 TCR-bearing  cells  of this  type  is 
dependent  upon  some  property  of the  TCR  transgenes 
themselves,  in this case, their early expression on DN thy- 
mocytes. 
If these DN DO-TCR  T  cells do arise without passing 
through  a  CD4+CD8 +,  double-positive  stage,  what  rele- 
vance does this have for the development ofT cells in nor- 
mal mice? In normal animals TCR  13 chains are expressed 
on DN thymocytes, but TCR ot chains are not, so there is no 
opportunity for positive selection ofDN  thymocytes in such 
animals. In normal animals TCR  [3 chains are expressed on 
DN  thymocytes  bound  to  pre-To~  chains  and  associated with CD3  (54).  It is thought that this combination signals 
to the thymocyte and thus induces expression of the CD4 
and CD8 genes as well as rearrangements at the el chain lo- 
cus (55, 56). It has been suggested that this signal is induced 
by binding of the TCR  [3 chain/pre-Tot complex to some 
unknown  ligand.  If this is so,  clearly ligation of complete 
TCR  or/]3  combinations at the DN  stage delivers a differ- 
ent signal, since this latter ligation does not appear to induce 
CD4  and CD8  expression. Perhaps the difference is a mat- 
ter of the affinity with which TCR]B/pre-Tci or TCR-oL/]3 
are engaged by their respective ligands. 
Finally, various theories have been suggested to account 
for the fact that the accessory proteins,  CD4  or CD8,  ex- 
pressed  by  T  cells,  usually  match  the  restriction  of the 
TCRs  they bear,  for  class  II  or  class  I  MHC.  Instructive 
theories suggest that positive selection of thymocytes by re- 
action with class II dictates CD4 expression by the selected 
cells  (17,  18,  57)  whereas  selective  theories  suggest  that 
thymocytes make a random choice and are then selected to 
mature  if they  express  the  CD4  or  CD8  protein  which 
matches  the  restriction specificity of their TCRs  (13-16). 
The  experiments  described in  this  article demonstrate,  as 
many experiments have done in the past, that this instruction 
cannot be absolute since clearly DO-TCR-bearing  T  cells 
that have been selected on IA  b do not express CD4. 
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